Introduction The Herpes Simplex Virus Treatment Market is experiencing steady growth due to the high global prevalence of herpes simplex virus (HSV) infections and increasing demand for effective antiviral therapies. Valued at USD 2.8 billion in 2024, the market is projected to reach USD 4.3 billion by 2034, growing at a compound annual growth rate (CAGR) of 5.5%. HSV types 1 and 2,...